References
- WHO. Ebola virus disease. Fact sheet N°103; Geneva (Switzerland); [Updated 2015 Aug; cited 2016 Jan 11]. Available from: http://www.who.int/mediacentre/factsheets/fs103/en/
- Frieden TR, Damon IK. Ebola in West Africa - CDC’s role in epidemic detection, control, and prevention. Emerging Infect Dis. 2015;21(11):1897–1905. [cited 2016 Jan 10]. Available from www.cdc.gov/eid
- WHO. Meeting summary of the WHO consultation on potential Ebola therapies and vaccines. Geneva (Switzerland); 2014 Sep 4-5 [cited 2016 Jan 10]. Available from: http://apps.who.int/iris/bitstream/10665/136103/1/WHO_EVD_Meet_EMP_14.1_eng.pdf?ua=1
- WHO. Interim guidance. Potential Ebola therapies and vaccines (based on 4–5 September 2014, consultation); Geneva (Switzerland); 2014 Nov 5 [cited 2016 Jan 10]. Available from: http://apps.who.int/iris/bitstream/10665/137590/1/WHO_EVD_HIS_EMP_14.1_eng.pdf?ua=1
- An R&D blueprint to action to prevent epidemics: accelerating R&D and saving lives. [ cited 2016 April 24]. Available from: http://www.who.int/csr/research-and-development/r_d_blueprint_brochure2015.pdf
- Moon S, Sridhar D, Pate MA, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the harvard-LSHTM independent panel on the global response to Ebola. Lancet. 2015 Nov 28;386:2204–2221.
- US FDA. Public Workshop - Clinical Trial Designs for Emerging Infectious Diseases; [cited 2016 Jan 10]. Available from: http://www.fda.gov/emergencypreparedness/counterterrorism/medicalcountermeasures/aboutmcmi/ucm466153.htm
- WHO. Emergency Use Assessment and Listing procedure (EUAL) for candidate vaccines for use in the context of a public health emergency; [cited 2016 Jan 10]. Available from: http://www.who.int/medicines/news/EUAL-vaccines_7July2015_MS.pdf
- Akanmori B, Bellah A, Ward M, et al. The African Vaccine Regulatory Forum (AVAREF): platform for collaboration in a public health emergency. WHO Drug Inform. 2015;29(2):127–132.
- Skerrit J, Moura Olivera JC, Arora A, et al. The International Coalition of Medicines Regulatory Authorities (ICMRA). WHO Drug Inform. 2015;29(1):3–5.